Having trouble accessing articles? Reset your cache.

Endocrine/Metabolic

INDICATION: Diabetes

Cell culture studies suggest inhibiting TGFBR1 could help treat GLIS3-mutant diabetes. Screening of a library of approved drugs, drug-like

Read the full 200 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE